Gilead Sciences

Gilead Sciences is a biopharmaceutical company that focuses on the discovery, development, and commercialization of innovative medicines in areas of unmet medical need. Established in 1987, Gilead has made significant contributions to the treatment of various diseases, particularly in the fields of HIV/AIDS, liver diseases, cancer, inflammatory diseases, and respiratory conditions.

The company is renowned for its commitment to advancing healthcare through scientific innovation and research. Gilead’s portfolio includes several groundbreaking therapies that have transformed the lives of patients worldwide. The company operates with a vision to improve patient outcomes by providing access to high-quality medicines.

Core Activities:

• Research and Development: Gilead invests heavily in R&D to discover new treatments and improve existing therapies.
• Commercialization: The company effectively brings its innovative products to market, ensuring they reach the patients who need them.
• Global Access: Gilead is dedicated to expanding access to its medicines, particularly in underserved populations.

With a strong emphasis on collaboration, Gilead partners with various stakeholders, including healthcare providers, governments, and non-profit organizations, to enhance public health initiatives. The company’s headquarters is located in Foster City, California, but it has a significant presence in the UK, contributing to local economies and healthcare systems.

Gilead Sciences remains at the forefront of biopharmaceutical innovation, driven by a mission to create a healthier world through the power of science.